FDA — authorised 14 January 2009
- Application: NDA022256
- Marketing authorisation holder: ABBVIE
- Local brand name: SAVELLA
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Milnacipram in United States
FDA authorised Milnacipram on 14 January 2009
Marketing authorisations
FDA
- Status: approved
Milnacipram in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Milnacipram approved in United States?
Yes. FDA authorised it on 14 January 2009; FDA has authorised it.
Who is the marketing authorisation holder for Milnacipram in United States?
ABBVIE holds the US marketing authorisation.